Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EVE Health GroupASX:EVE EV-to-EBIT is -2.93 as of Aug. 08, 2026. The stock has 6 warning signs investors should review. Among 1,555 Consumer Packaged Goods companies, EVE Health Group ranks worse than 64308.62% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
EVE Health Group's Enterprise Value for the quarter that ended in Dec. 2025 was A$5.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EVE Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group EV-to-EBIT Related Terms
EVE Health Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for EVE Health Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, EVE Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where EVE Health Group's EV-to-EBIT falls into.
EVE Health Group's current Enterprise Value is A$4.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EVE Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group (ASX:EVE) has a EV-to-EBIT of -2.93 as of Aug. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #999999 out of 1555 companies in the Consumer Packaged Goods industry.
Is EVE Health Group's EV-to-EBIT too high?
EVE Health Group's current EV-to-EBIT is -2.93. Based on the distribution chart, EVE Health Group ranks #999999 out of 1555 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's EV-to-EBIT compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #999999 out of 1555 companies for EV-to-EBIT. This places EVE Health Group in the lower half of its industry. The industry median EV-to-EBIT is 12.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.04, based on 1,555 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current EV-to-EBIT is -2.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 60% above its estimated fair value. The current EV-to-EBIT is -2.93. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current EV-to-EBIT is -2.93 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 
